Mobile van brings HIV prevention and drug checking to baltimore streets

NCT ID NCT05977881

Completed Prevention Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a van-based program in Baltimore that offered drug checking and HIV prevention medication (PrEP) to people who use drugs. Nearly 500 participants were recruited to see if the program helped them start or stay on PrEP and reduce risky behaviors. The goal was to lower both HIV infections and overdose deaths in the community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PrEP (pre-exposure prophylaxis) and drug-checking services
What this could lead to: If successful, this approach could provide a practical way to lower HIV and overdose rates among people who use drugs in urban areas.
What could go wrong: The study is completed but results are not yet widely confirmed; the intervention was offered broadly, so individual impact is hard to measure. Real-world effectiveness may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Overdose Harm Reduction HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS

Contacts and locations

Locations

Johns Hopkins School of Public Health

Baltimore, Maryland, 21205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.